part

Cobalt-60 Source (Gamma Knife / Co-60 Teletherapy)

The Co-60 sealed source that defines the Leksell Gamma Knife family of stereotactic-radiosurgery devices and the much-smaller installed base of legacy Co-60 teletherapy units (largely retired in developed-market clinical use but still operational in some lower-resource settings). Co-60 emits gamma photons at 1.17 and 1.33 MeV (mean ~1.25 MeV) — useful for SRS / external-beam radiation therapy at energies analogous to ~4 MV photon beams from a low-energy linac.

The Gamma Knife platform uses multiple small Co-60 sources (typically 192 sources on Perfexion / Icon, 201 sources on legacy 4C / U) arranged geometrically around a central focal point. Each source produces a narrow beam aimed at a common isocenter; the patient's head is positioned at the isocenter under stereotactic immobilization. The combined dose at the focal point is therapeutic; the dose anywhere else is sub-therapeutic. This geometric multi-source convergence is the principle that gives Gamma Knife its name and its clinical positioning vs linac-based SRS.

Co-60 sources have a 5.27-year half-life — much longer than brachy Ir-192 (74 days) but still finite. Gamma Knife sources are replaced in coordinated multi-source change-out events, typically every 5–7 years depending on clinical workload and acceptable treatment-time growth. Source-change events for Gamma Knife are major scheduled service procedures involving vendor-coordinated source removal + transport + replacement + safety surveys.

Fits

Distinctive technology

  • Co-60 isotope — 5.27-year half-life, dual-photon emission at 1.17 and 1.33 MeV.
  • Sealed source — metallic Co-60 inside a welded stainless-steel capsule.
  • Multi-source geometric convergence — Gamma Knife's defining architectural feature.
  • Predictable decay rate — output drops by ~50% over 5.27 years; treatment times grow correspondingly between source-change events.
  • Activation-product handling — Co-60 is itself a neutron-activated product (Co-59 + n → Co-60); source production is at specialty nuclear-reactor facilities.

Failure modes

  • Decay — the predominant scheduled-replacement mode. Treatment times grow as activity falls; clinical workflow eventually reaches a threshold where source change is justified.
  • Source-positioning drift — Gamma Knife depends on geometric source positioning being precise; mechanical drift in the source carriers can affect dose-distribution accuracy. Daily QA detects this.
  • Source-capsule integrity events — extremely rare; routine wipe-tests verify capsule integrity.
  • Source-shutter mechanism failure — Gamma Knife uses mechanical shutters / collimator helmets to control which sources contribute to the active beam. Shutter / helmet mechanism failures occur and are addressed through service.

Diagnosis

  • Daily QA dose-output measurement — Gamma Knife output trending vs predicted decay curve. Deviations from prediction indicate either source-positioning issues or measurement issues.
  • Source-positioning QA — Winston-Lutz-class geometric verification at scheduled intervals.
  • Wipe-test surveys — capsule integrity verification.
  • Service-log review of mechanical-event history.

Replacement path

Gamma Knife source change is a multi-week multi-stakeholder coordinated service procedure:

  • NRC / Agreement-State licensing — receipt and disposal documentation maintained.
  • DOT shipping — incoming and outgoing source-transport per hazardous-materials regulations.
  • Vendor-managed source-loading — Elekta-coordinated procedure with site RSO and physicist participation.
  • Source-strength verification post-load.
  • TPS / planning-system update — new source-strength reference loaded into the planning system.
  • Old source disposal — vendor-managed return shipping to source manufacturer for decay-storage / recycling.
  • Site downtime during source change is meaningful — typically 1–2 weeks for the loading + verification process, with no clinical treatments during that window.

Field notes

  • Gamma Knife source change is the single largest service event in a Gamma Knife program's operating life — comparable in cost / complexity to a major linac component refresh.
  • Decommissioning a Gamma Knife is a complex regulatory event because of the source disposal scale (~200 sealed sources to be removed from the facility under controlled conditions).
  • Linac-based SRS as a competing technology has displaced new Gamma Knife sales in much of the developed market — the operating-cost advantages of linac-platform dose delivery (no source-change overhead, dual-modality use as both SRS and conventional radiation-therapy machine) outweigh the geometric-convergence advantages of multi-source Co-60 in many programs. Established Gamma Knife centers continue to operate; the installed base is mature.

Related